Process Intensification: ROI Realities & Implementation Considerations

Source: Sartorius

Susan Dexter, CTO at Sonnet Biotherapeutics and process intensification pioneer Parrish Galliher discuss cost reduction and ROI realities associated with process intensification in this segment of the Bioprocess Online Live event “Upstream Process Intensification In Practice.” They suggest that the ROI on process intensification initiatives are ultimately dependent on your ability to increase yield, cover the key metrics and performance indicators necessary to measure those outcomes, and walk us through the role of single use technology and common implementation challenges. 

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online